Literature DB >> 11302963

Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice.

J I Semple1, J L Newton, B R Westley, F E May.   

Abstract

BACKGROUND: TFF2, a member of the trefoil factor family of proteins, is a glycosylated protein of 106 amino acids. It is secreted by gastric antral and pyloric glands and by Brunner's glands of the duodenum. TFF2 is found in high concentrations around sites of ulceration. It stimulates cell motility and is probably the principal cytoprotective trefoil peptide in the stomach. AIMS: To determine if production of TFF2 follows a circadian rhythm and to measure changes in secretion of TFF2 in response to food intake and during sleep.
SUBJECTS: Young healthy adults were recruited. They were asymptomatic and were not receiving medication. The 24 hour regimen was designed to allow normal stimulation of gastric secretion in response to food intake and sleep. Gastric juice was collected two hourly via a nasogastric tube.
METHODS: Glycosylated and non-glycosylated TFF2 proteins were measured by quantitative western transfer analysis. The results were analysed statistically using SPSS software.
RESULTS: There was a dramatic diurnal variation in the concentration of TFF2. The mean concentration was lowest in the early evening (0.29 microg/ml), increased gradually during the evening, and then sharply during the night to reach 7.9 microg/ml. The ratio of glycosylated to non-glycosylated TFF2 varied and was higher during the night than in the afternoon. pH, total protein, and pepsin concentrations in gastric juice did not vary significantly over 24 hours.
CONCLUSION: The data suggest that diurnal variations in TFF2 secretion occur independently of pepsin and gastric acid secretion. The concentration of glycosylated TFF2 in the gastric lumen falls in response to food intake. TFF2 secretion increases during inactivity and sleep. These results suggest that secretion of TFF2 in the stomach is highest during the night and that the cytoprotective effects of TFF2 on the gastric mucosa occur mainly during sleep.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302963      PMCID: PMC1728301          DOI: 10.1136/gut.48.5.648

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

Review 1.  Diurnal profiles of gastrointestinal regulatory peptides.

Authors:  R Jorde; P G Burhol
Journal:  Scand J Gastroenterol       Date:  1985-01       Impact factor: 2.423

2.  Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease.

Authors:  N A Wright; R Poulsom; G Stamp; S Van Noorden; C Sarraf; G Elia; D Ahnen; R Jeffery; J Longcroft; C Pike
Journal:  Gastroenterology       Date:  1993-01       Impact factor: 22.682

3.  Glycoforms modify the dynamic stability and functional activity of an enzyme.

Authors:  P M Rudd; H C Joao; E Coghill; P Fiten; M R Saunders; G Opdenakker; R A Dwek
Journal:  Biochemistry       Date:  1994-01-11       Impact factor: 3.162

4.  Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry.

Authors:  N H Piggott; J A Henry; F E May; B R Westley
Journal:  J Pathol       Date:  1991-02       Impact factor: 7.996

5.  Crystal structure of a disulfide-linked "trefoil" motif found in a large family of putative growth factors.

Authors:  A De; D G Brown; M A Gorman; M Carr; M R Sanderson; P S Freemont
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

6.  Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach.

Authors:  A M Hanby; R Poulsom; S Singh; G Elia; R E Jeffery; N A Wright
Journal:  Gastroenterology       Date:  1993-10       Impact factor: 22.682

7.  Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues.

Authors:  N A Wright; R Poulsom; G W Stamp; P A Hall; R E Jeffery; J M Longcroft; M C Rio; C Tomasetto; P Chambon
Journal:  J Pathol       Date:  1990-12       Impact factor: 7.996

8.  Pancreatic spasmolytic polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects.

Authors:  K D Jørgensen; B Diamant; K H Jørgensen; L Thim
Journal:  Regul Pept       Date:  1982-03

9.  Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast.

Authors:  L Thim; K Norris; F Norris; P F Nielsen; S E Bjørn; M Christensen; J Petersen
Journal:  FEBS Lett       Date:  1993-03-08       Impact factor: 4.124

10.  hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma.

Authors:  C Tomasetto; M C Rio; C Gautier; C Wolf; M Hareuveni; P Chambon; R Lathe
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

View more
  12 in total

Review 1.  Effect of age-related changes in gastric physiology on tolerability of medications for older people.

Authors:  Julia L Newton
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 2.  Circadian clocks in the digestive system.

Authors:  Anneleen Segers; Inge Depoortere
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-02       Impact factor: 46.802

3.  Pathophysiological investigation of the gastric surface mucous gel layer of patients with Helicobacter pylori infection by using immunoassays for trefoil factor family 2 and gastric gland mucous cell-type mucin in gastric juice.

Authors:  Seiko Kubota; Kazuyoshi Yamauchi; Mitsutoshi Sugano; Kenji Kawasaki; Atsushi Sugiyama; Kenji Matsuzawa; Taiji Akamatsu; Yasukazu Ohmoto; Hiroyoshi Ota
Journal:  Dig Dis Sci       Date:  2011-05-11       Impact factor: 3.199

4.  Gastroprotective peptide trefoil factor family 2 gene is activated by upstream stimulating factor but not by c-Myc in gastrointestinal cancer cells.

Authors:  E Al-azzeh; O Dittrich; J Vervoorts; N Blin; P Gött; B Lüscher
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

Review 5.  Circadian rhythms: a regulator of gastrointestinal health and dysfunction.

Authors:  Robin M Voigt; Christopher B Forsyth; Ali Keshavarzian
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2019-03-25       Impact factor: 3.869

6.  Correlates shift work with increased risk of gastrointestinal complaints or frequency of gastritis or peptic ulcer in H. pylori-infected shift workers?

Authors:  Anke van Mark; Michael Spallek; David A Groneberg; Richard Kessel; Stephan W Weiler
Journal:  Int Arch Occup Environ Health       Date:  2009-12-11       Impact factor: 3.015

7.  Aspirin for the older person: report of a meeting at the Royal Society of Medicine, London, 3rd November 2011.

Authors:  J Armitage; J Cuzick; P Elwood; M Longley; A Perkins; K Spencer; H Turner; S Porch; S Lyness; J Kennedy; Gn Henderson
Journal:  Ecancermedicalscience       Date:  2012-02-28

Review 8.  Trefoil Factor Family (TFF) Peptides and Their Diverse Molecular Functions in Mucus Barrier Protection and More: Changing the Paradigm.

Authors:  Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

9.  Different Forms of TFF2, A Lectin of the Human Gastric Mucus Barrier: In Vitro Binding Studies.

Authors:  Franziska Heuer; René Stürmer; Jörn Heuer; Thomas Kalinski; Antje Lemke; Frank Meyer; Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2019-11-22       Impact factor: 5.923

Review 10.  Improving the gastrointestinal tolerability of aspirin in older people.

Authors:  Julia L Newton
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.